Michael & Susan Dell Foundation Diversified Active

CIK: 0001599858 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $126,479 (100.0% shares, 0.0% debt)

Holdings (7)

CCI CROWN CASTLE INTL CORP NEW 43.1%

Value ($000) $54,516 Shares 544,185 Est. Cost $54.14 Unrealized +26.4%

JPM JPMORGAN CHASE & CO 22.7%

Value ($000) $28,686 Shares 313,853 Est. Cost $50.34 Unrealized +36.1%

— AETNA INC NEW 15.0%

Value ($000) $18,920 Shares 124,616 Est. Cost $68.59 Unrealized —

— INTREXON CORP 8.2%

Value ($000) $10,428 Shares 432,878 Est. Cost $25.55 Unrealized —

WMB WILLIAMS COS INC DEL 5.4%

Value ($000) $6,824 Shares 225,363 Est. Cost $18.55 Unrealized +0.6%

BRK/B BERKSHIRE HATHAWAY INC DEL 5.3%

Value ($000) $6,690 Shares 39,500 Est. Cost $132.58 Unrealized +25.5%

— ZIOPHARM ONCOLOGY INC 0.3%

Value ($000) $415 Shares 66,749 Est. Cost $12.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CCI	CROWN CASTLE INTL CORP NEW	544,185	$54,516	43.1%	$54.14	+26.4%	COM	22822V101
JPM	JPMORGAN CHASE & CO	313,853	$28,686	22.7%	$50.34	+36.1%	COM	46625H100
—	AETNA INC NEW	124,616	$18,920	15.0%	$68.59	—	COM	00817Y108
—	INTREXON CORP	432,878	$10,428	8.2%	$25.55	—	COM	46122T102
WMB	WILLIAMS COS INC DEL	225,363	$6,824	5.4%	$18.55	+0.6%	COM	969457100
BRK/B	BERKSHIRE HATHAWAY INC DEL	39,500	$6,690	5.3%	$132.58	+25.5%	CL B NEW	084670702
—	ZIOPHARM ONCOLOGY INC	66,749	$415	0.3%	$12.00	—	COM	98973P101